CN117599247B - Silk fibroin microcarrier skin filling preparation, and preparation method and application thereof - Google Patents
Silk fibroin microcarrier skin filling preparation, and preparation method and application thereof Download PDFInfo
- Publication number
- CN117599247B CN117599247B CN202311721348.5A CN202311721348A CN117599247B CN 117599247 B CN117599247 B CN 117599247B CN 202311721348 A CN202311721348 A CN 202311721348A CN 117599247 B CN117599247 B CN 117599247B
- Authority
- CN
- China
- Prior art keywords
- silk fibroin
- solution
- silk
- microcarrier
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010022355 Fibroins Proteins 0.000 title claims abstract description 157
- 238000002360 preparation method Methods 0.000 title claims abstract description 78
- 238000011049 filling Methods 0.000 title claims abstract description 74
- 239000000243 solution Substances 0.000 claims abstract description 103
- 239000007864 aqueous solution Substances 0.000 claims abstract description 85
- 239000002131 composite material Substances 0.000 claims abstract description 53
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 44
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 38
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 30
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 30
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 30
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 28
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 28
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 28
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 22
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 22
- 239000011718 vitamin C Substances 0.000 claims abstract description 22
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 15
- 240000000249 Morus alba Species 0.000 claims abstract description 15
- 238000001035 drying Methods 0.000 claims abstract description 14
- 239000002244 precipitate Substances 0.000 claims description 36
- 239000002904 solvent Substances 0.000 claims description 33
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 32
- 102000004169 proteins and genes Human genes 0.000 claims description 31
- 108090000623 proteins and genes Proteins 0.000 claims description 31
- 239000012670 alkaline solution Substances 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 18
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 17
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 16
- 229920002556 Polyethylene Glycol 300 Polymers 0.000 claims description 15
- 239000012154 double-distilled water Substances 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 4
- YLIMHFXLIKETBC-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCC[Na] YLIMHFXLIKETBC-UHFFFAOYSA-N 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract 2
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 50
- 230000000694 effects Effects 0.000 description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 238000000502 dialysis Methods 0.000 description 18
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 17
- 229930003571 Vitamin B5 Natural products 0.000 description 17
- 229960002079 calcium pantothenate Drugs 0.000 description 17
- 235000009492 vitamin B5 Nutrition 0.000 description 17
- 239000011675 vitamin B5 Substances 0.000 description 17
- 238000012360 testing method Methods 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 13
- 238000011068 loading method Methods 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000008367 deionised water Substances 0.000 description 12
- 229910021641 deionized water Inorganic materials 0.000 description 12
- 229940067741 sodium octyl sulfate Drugs 0.000 description 12
- WFRKJMRGXGWHBM-UHFFFAOYSA-M sodium;octyl sulfate Chemical group [Na+].CCCCCCCCOS([O-])(=O)=O WFRKJMRGXGWHBM-UHFFFAOYSA-M 0.000 description 12
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 11
- 238000000338 in vitro Methods 0.000 description 9
- 239000002202 Polyethylene glycol Substances 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- 235000012730 carminic acid Nutrition 0.000 description 7
- 239000000945 filler Substances 0.000 description 7
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 238000010828 elution Methods 0.000 description 6
- 239000012065 filter cake Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 125000003201 pantothenic acid group Chemical group 0.000 description 6
- 239000012460 protein solution Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000000967 suction filtration Methods 0.000 description 6
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 6
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 102000012422 Collagen Type I Human genes 0.000 description 4
- 108010022452 Collagen Type I Proteins 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 description 3
- 229940097043 glucuronic acid Drugs 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- -1 porous scaffolds Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
技术领域Technical Field
本发明属于丝素蛋白技术领域,具体涉及一种丝素蛋白微载体皮肤填充制剂及其制备方法和应用。The invention belongs to the technical field of silk fibroin, and in particular relates to a silk fibroin microcarrier skin filling preparation and a preparation method and application thereof.
背景技术Background technique
丝素蛋白是一种高分子蛋白,主要含有18中氨基酸,丝素蛋白具有出色的机械性能、生物相容性和生物降解性,在生物材料和组织工程领域具有很好的应用前景。Silk fibroin is a high molecular weight protein that mainly contains 18 amino acids. Silk fibroin has excellent mechanical properties, biocompatibility and biodegradability, and has good application prospects in the fields of biomaterials and tissue engineering.
目前,丝素蛋白以多种形式被应用(林楠,左保齐.医用再生丝素蛋白材料制备与研究进展[J].现代丝绸科学与技术,2020,35(3):9.),包括:At present, silk fibroin is used in various forms (Lin Nan, Zuo Baoqi. Preparation and research progress of medical regenerated silk fibroin materials [J]. Modern Silk Science and Technology, 2020, 35(3):9.), including:
(1)制备再生丝素溶液,具体包括脱胶步骤、溶解步骤。由于丝素蛋白和丝胶蛋白的协同作用会产生一定的免疫反应,所以脱胶是将丝素蛋白用作生物材料的关键步骤。蚕丝经过脱胶后可以溶解,溶解后的丝素蛋白可以制成多种剂型。(1) preparing a regenerated silk fibroin solution, specifically including a degumming step and a dissolving step. Since the synergistic effect of silk fibroin and sericin will produce a certain immune response, degumming is a key step in using silk fibroin as a biomaterial. Silk can be dissolved after degumming, and the dissolved silk fibroin can be made into a variety of dosage forms.
(2)制备丝素蛋白材料,包括制备水凝胶、多孔支架、薄膜、微球等材料。水凝胶的制备方法包括旋流剪切、超声振荡、酸处理、自然凝胶等;多孔支架通过冷冻干燥、粒子致孔等步骤制备;薄膜采用浇筑法等方法制备;微球采用喷雾干燥、冷冻干燥等方法制备。(2) Preparation of silk fibroin materials, including preparation of hydrogels, porous scaffolds, films, microspheres and other materials. The preparation methods of hydrogels include cyclonic shearing, ultrasonic oscillation, acid treatment, natural gelation, etc.; porous scaffolds are prepared by freeze drying, particle pore formation and other steps; films are prepared by casting and other methods; microspheres are prepared by spray drying, freeze drying and other methods.
皮肤填充制剂的主要作用是组织修复,通过局部注射的微创疗法,将具有皮肤组织修复功能的物质注入结构松弛的软组织局部,以改善皮肤松弛度,从而使该组织恢复正常的功能和外观。已有专利研究了利用丝素蛋白制备组织填充材料技术,如中国专利CN102836465B记载的方案,该专利将丝素蛋白与透明质酸复合,制备了复合凝胶,使得凝胶的体外抗酶解能显著提高,进而减缓了复合凝胶的降解速度,最终可延长复合凝胶在组织修补和填充的作用时间,另外,该专利由于在丝素蛋白颗粒中增加了透明质酸,增加了吸水性和储水功能,所以制得的复合凝胶储水功能和填充效果也不错。然而仅有透明质酸的皮肤修复功能,还是不能满足皮肤填充剂的需求,有些皮肤差的患者需要增加其他辅助因子来改善皮肤状况。The main function of skin filling preparations is tissue repair. Through local injection of minimally invasive therapy, substances with skin tissue repair function are injected into the local soft tissue with loose structure to improve skin laxity, so that the tissue can restore normal function and appearance. Existing patents have studied the technology of preparing tissue filling materials using silk fibroin, such as the scheme recorded in Chinese patent CN102836465B. The patent combines silk fibroin with hyaluronic acid to prepare a composite gel, which significantly improves the in vitro anti-enzymatic ability of the gel, thereby slowing down the degradation rate of the composite gel, and finally prolonging the action time of the composite gel in tissue repair and filling. In addition, the patent adds hyaluronic acid to the silk fibroin particles, which increases the water absorption and water storage function, so the water storage function and filling effect of the prepared composite gel are also good. However, the skin repair function of hyaluronic acid alone cannot meet the needs of skin fillers. Some patients with poor skin need to add other auxiliary factors to improve skin conditions.
发明内容Summary of the invention
为了解决“增加其他的辅助因子来改善皮肤状况”的技术问题,我们以丝素蛋白等物质为原料制成凝胶,开发出一种新的丝素蛋白微载体皮肤填充制剂。具体的,本发明提供一种丝素蛋白微载体皮肤填充制剂及其制备方法和应用,相比于现有技术的复合凝胶,我们的技术方案可以负载维生素B5、I型胶原蛋白等多种辅助因子,辅助因子负载率高,有助于改善皮肤状况。In order to solve the technical problem of "adding other auxiliary factors to improve skin conditions", we use silk fibroin and other substances as raw materials to make gel and develop a new silk fibroin microcarrier skin filling preparation. Specifically, the present invention provides a silk fibroin microcarrier skin filling preparation and its preparation method and application. Compared with the composite gel of the prior art, our technical solution can load multiple auxiliary factors such as vitamin B5 and type I collagen, with a high auxiliary factor loading rate, which helps to improve skin conditions.
本发明的一个目的是提供一种丝素蛋白微载体皮肤填充制剂的制备方法,包括:An object of the present invention is to provide a method for preparing a silk fibroin microcarrier skin filling preparation, comprising:
桑蚕丝脱胶、浓缩、干燥,得到干燥丝素;Degumming, concentrating and drying the mulberry silk to obtain dry silk fibroin;
干燥丝素配置成水溶液,该水溶液与维生素C混合,搅拌,冻干,得到VC负载丝素蛋白;The dried silk fibroin is prepared into an aqueous solution, the aqueous solution is mixed with vitamin C, stirred, and freeze-dried to obtain VC-loaded silk fibroin;
将VC负载丝素蛋白配置成丝素水溶液,将丝素水溶液、透明质酸、麦芽糊精与交联剂混合,35-40℃静置,得到复合凝胶,灭菌,即得到丝素蛋白微载体皮肤填充制剂。The VC-loaded silk fibroin is prepared into a silk fibroin aqueous solution, and the silk fibroin aqueous solution, hyaluronic acid, maltodextrin and a cross-linking agent are mixed, and allowed to stand at 35-40° C. to obtain a composite gel, and then sterilized to obtain a silk fibroin microcarrier skin filling preparation.
优选的,上述丝素蛋白微载体皮肤填充制剂的制备方法,干燥丝素用双蒸水作为溶剂,配置成质量分数5-10%的水溶液,该水溶液与维生素C按照90-110:1的质量比例混合,搅拌15-30min,冻干,得到VC负载丝素蛋白。Preferably, in the preparation method of the above-mentioned silk fibroin microcarrier skin filling preparation, double distilled water is used as a solvent for drying silk fibroin to prepare an aqueous solution with a mass fraction of 5-10%, the aqueous solution is mixed with vitamin C in a mass ratio of 90-110:1, stirred for 15-30 minutes, and freeze-dried to obtain VC-loaded silk fibroin.
优选的,上述丝素蛋白微载体皮肤填充制剂的制备方法,干燥丝素用双蒸水作为溶剂,配置成质量分数5%的水溶液,该水溶液与维生素C按照100:1的质量比例混合,搅拌20min,冻干,得到VC负载丝素蛋白。Preferably, in the preparation method of the above-mentioned silk fibroin microcarrier skin filling preparation, double distilled water is used as a solvent for drying silk fibroin to prepare a 5% by mass aqueous solution, the aqueous solution is mixed with vitamin C in a mass ratio of 100:1, stirred for 20 minutes, and freeze-dried to obtain VC-loaded silk fibroin.
优选的,上述丝素蛋白微载体皮肤填充制剂的制备方法,以PEG300-PEG600为溶剂,将VC负载丝素蛋白配置成30-40g/L的丝素溶液,将丝素溶液、透明质酸、麦芽糊精与交联剂按照10:1:0.5-0.8:0.2-0.5的质量比例混合,35-40℃静置,得到复合凝胶。麦芽糊精的加入可以提高复合凝胶的辅助因子负载性能。Preferably, the preparation method of the above-mentioned silk fibroin microcarrier skin filling preparation is to use PEG300-PEG600 as solvent, configure VC loaded silk fibroin into a 30-40g/L silk fibroin solution, mix the silk fibroin solution, hyaluronic acid, maltodextrin and cross-linking agent in a mass ratio of 10:1:0.5-0.8:0.2-0.5, and stand at 35-40° C. to obtain a composite gel. The addition of maltodextrin can improve the auxiliary factor loading performance of the composite gel.
优选的,上述丝素蛋白微载体皮肤填充制剂的制备方法,以PEG300为溶剂,将VC负载丝素蛋白配置成30g/L的丝素溶液,将丝素溶液、透明质酸、麦芽糊精与交联剂按照10:1:0.5:0.2的质量比例混合,40℃静置,得到复合凝胶。Preferably, the preparation method of the above-mentioned silk fibroin microcarrier skin filler preparation is to use PEG300 as solvent, configure VC-loaded silk fibroin into a 30 g/L silk solution, mix the silk solution, hyaluronic acid, maltodextrin and cross-linking agent in a mass ratio of 10:1:0.5:0.2, and let stand at 40°C to obtain a composite gel.
优选的,上述丝素蛋白微载体皮肤填充制剂的制备方法,交联剂为辛基硫酸钠溶液、十二烷基磺酸钠中的一种或几种。进一步优选的,交联剂为浓度15g/L的辛基硫酸钠溶液、15g/L十二烷基磺酸钠的一种或几种。优选的,将所述交联剂与高分子化合物混合后,再与丝素溶液、麦芽糊精混合,35-40℃静置,得到复合凝胶。Preferably, in the preparation method of the above-mentioned silk fibroin microcarrier skin filling preparation, the crosslinking agent is one or more of octyl sodium sulfate solution and sodium dodecyl sulfate. Further preferably, the crosslinking agent is one or more of octyl sodium sulfate solution with a concentration of 15g/L and sodium dodecyl sulfate with a concentration of 15g/L. Preferably, after the crosslinking agent is mixed with the polymer compound, it is mixed with the silk fibroin solution and maltodextrin, and allowed to stand at 35-40°C to obtain a composite gel.
在适合交联的条件下,高分子化合物在所述交联剂的存在下发生交联反应,例如,所述高分子化合物为选自下组中的一种或多种:透明质酸、透明质酸钠、壳聚糖、羧甲基壳聚糖、几丁质、羧甲基几丁质、胶原蛋白、明胶、丝素蛋白、羧甲基葡聚糖、羧甲基纤维素、氨基聚乙二醇、羧基聚乙二醇。所述高分子化合物在溶液中的起始质量浓度为0.5%-10%,例如0.6%-8%。Under conditions suitable for cross-linking, the polymer compound undergoes a cross-linking reaction in the presence of the cross-linking agent, for example, the polymer compound is one or more selected from the group consisting of hyaluronic acid, sodium hyaluronate, chitosan, carboxymethyl chitosan, chitin, carboxymethyl chitin, collagen, gelatin, silk fibroin, carboxymethyl dextran, carboxymethyl cellulose, amino polyethylene glycol, carboxyl polyethylene glycol. The initial mass concentration of the polymer compound in the solution is 0.5%-10%, for example 0.6%-8%.
优选的,上述丝素蛋白微载体皮肤填充制剂的制备方法,所述脱胶的方法包括:Preferably, in the preparation method of the above-mentioned silk fibroin microcarrier skin filling preparation, the degumming method comprises:
(1)用碱溶液煮沸桑蚕丝30min,过滤,收集沉淀;其中,所述碱溶液为质量分数0.05%的碳酸钠水溶液与质量分数0.03%的L-谷氨酸钠水溶液按照20:1体积比例混合而成的;(1) boiling the silk with an alkaline solution for 30 minutes, filtering, and collecting the precipitate; wherein the alkaline solution is a mixture of a sodium carbonate aqueous solution with a mass fraction of 0.05% and a sodium L-glutamate aqueous solution with a mass fraction of 0.03% in a volume ratio of 20:1;
(2)将沉淀继续用所述碱溶液水溶液煮沸桑蚕丝30min,收集溶液;(2) boiling the precipitate with the alkaline solution for 30 minutes and collecting the solution;
(3)重复(2)操作,直至桑蚕丝脱胶完全,脱胶完全的物料称作丝素蛋白溶液。(3) Repeat step (2) until the silk is completely degummed. The completely degummed material is called silk fibroin solution.
本发明还提供了一种上述方法制备的丝素蛋白微载体皮肤填充制剂。The present invention also provides a silk fibroin microcarrier skin filling preparation prepared by the method.
本发明还提供了一种负载辅助因子的丝素蛋白微载体皮肤填充制剂,制备方法如下:桑蚕丝脱胶、干燥,得到干燥丝素;The present invention also provides a silk fibroin microcarrier skin filling preparation loaded with auxiliary factors, and the preparation method is as follows: degumming and drying mulberry silk to obtain dry silk fibroin;
干燥丝素配置成水溶液,该水溶液与维生素C混合,搅拌,冻干,得到VC负载丝素蛋白;The dried silk fibroin is prepared into an aqueous solution, the aqueous solution is mixed with vitamin C, stirred, and freeze-dried to obtain VC-loaded silk fibroin;
以PEG300-PEG600为溶剂,将VC负载丝素蛋白配置成丝素溶液,将丝素溶液、透明质酸、麦芽糊精、辅助因子与交联剂按照10:1:0.5-0.8:0.1:0.2-0.5的质量比例混合,35-40℃静置,得到复合凝胶,灭菌,即得到丝素蛋白微载体皮肤填充制剂。优选的,采用PEG300、PEG400、或者PEG600为溶剂。Using PEG300-PEG600 as solvent, VC loaded silk protein is prepared into silk solution, silk solution, hyaluronic acid, maltodextrin, auxiliary factor and cross-linking agent are mixed in a mass ratio of 10:1:0.5-0.8:0.1:0.2-0.5, and allowed to stand at 35-40°C to obtain a composite gel, which is sterilized to obtain a silk protein microcarrier skin filling preparation. Preferably, PEG300, PEG400 or PEG600 is used as solvent.
需要说明的是,在本发明的发明构思下,辅助因子可以是以下选择:维生素B5、皮肤生长因子、维生素E、维生素A、I型胶原蛋白等具有皮肤修复效果的任何物质。It should be noted that, under the inventive concept of the present invention, the auxiliary factors can be selected from the following: vitamin B5, skin growth factor, vitamin E, vitamin A, type I collagen and any other substance with skin repair effect.
本发明还提供了一种丝素蛋白微载体皮肤填充制剂的应用,具体的,丝素蛋白微载体皮肤填充制剂用于填充皮肤皱纹处或皮肤凹陷处。The present invention also provides an application of a silk fibroin microcarrier skin filling preparation. Specifically, the silk fibroin microcarrier skin filling preparation is used to fill skin wrinkles or skin depressions.
与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
本发明通过对丝素蛋白进行改良,使其先负载VC,然后再用于制备填充制剂,这样能提高填充制剂的抗酶解能力,呈现好的皮肤填充效果。原理:丝素蛋白具有吸附性能,已有研究显示其可以吸附金属,本发明利用丝素蛋白吸附VC,然后再用该VC负载丝素蛋白制备填充制剂,既能将VC包裹入填充制剂中,作为营养成分使用,还能提高填充制剂的抗酶解能力,提高材料填充皮肤的有效性。The present invention improves silk fibroin so that it is first loaded with VC and then used to prepare a filling preparation, which can improve the anti-enzymatic ability of the filling preparation and present a good skin filling effect. Principle: Silk fibroin has adsorption properties. Studies have shown that it can adsorb metals. The present invention uses silk fibroin to adsorb VC, and then uses the VC to load silk fibroin to prepare a filling preparation. VC can be wrapped in the filling preparation and used as a nutrient component, and the anti-enzymatic ability of the filling preparation can be improved, thereby improving the effectiveness of the material in filling the skin.
进一步的,本发明中,麦芽糊精与改良的丝素蛋白溶液组合使用,制成的填充制剂抗酶解效果和辅助因子负载性能均更好。原理:麦芽糊精是介于淀粉和淀粉糖之间的低转化产品,具有填充效果,载体性好,稳定性也好,医药领域常用麦芽糊精作为药物载体,本发明考虑到麦芽糊精和维生素B5、I型胶原蛋白等多种辅助因子化学结构,提供一种具体的负载方法,在本发明的负载方法下,对辅助因子的负载率高,且制得的填充制剂的抗酶解性能也得到提高。Furthermore, in the present invention, maltodextrin is used in combination with a modified silk fibroin solution, and the prepared filling preparation has better anti-enzymatic effect and auxiliary factor loading performance. Principle: Maltodextrin is a low-conversion product between starch and starch sugar, has a filling effect, good carrier properties, and good stability. Maltodextrin is commonly used as a drug carrier in the medical field. The present invention takes into account the chemical structures of maltodextrin and various auxiliary factors such as vitamin B5 and type I collagen, and provides a specific loading method. Under the loading method of the present invention, the loading rate of the auxiliary factor is high, and the anti-enzymatic performance of the prepared filling preparation is also improved.
基于上述原理和我们的实验结果,本发明制备的丝素蛋白微载体皮肤填充制剂抗酶解效果和辅助因子负载性能好,生物相容性也好,应用价值高。Based on the above principles and our experimental results, the silk fibroin microcarrier skin filling preparation prepared by the present invention has good anti-enzymatic effect and auxiliary factor loading performance, good biocompatibility, and high application value.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1受试志愿者1的皮肤填充结果图,A,填充前,B填充后。Figure 1 Skin filling results of volunteer 1, A, before filling, B, after filling.
图2受试志愿者2的皮肤填充结果图,A,填充前,B填充后。Figure 2 Skin filling results of volunteer 2, A, before filling, B, after filling.
图3受试志愿者3的皮肤填充结果图,A,填充前,B填充后。Figure 3 Skin filling results of volunteer 3, A, before filling, B, after filling.
图1、图2和图3中,箭头所指方向为填充位置。In Figures 1, 2 and 3, the direction indicated by the arrow is the filling position.
具体实施方式Detailed ways
为了使本领域技术人员更好地理解本发明的技术方案能予以实施,下面结合具体实施例和附图对本发明作进一步说明。In order to enable those skilled in the art to better understand and implement the technical solution of the present invention, the present invention is further described below in conjunction with specific embodiments and drawings.
在本发明的描述中,如未特殊说明,所用试剂均为市售,所用方法均为本领域常规技术。In the description of the present invention, unless otherwise specified, all reagents used are commercially available and all methods used are conventional techniques in the art.
1、主要实验试剂1. Main experimental reagents
桑蚕丝:浙江市售,是天然纤维。是将桑蚕茧剪开,去除其内的蛹和蜕皮,获得白净的茧壳。Mulberry silk: Available in Zhejiang, it is a natural fiber. It is made by cutting open the silkworm cocoons, removing the pupae and molts inside, and obtaining the white cocoon shell.
I型胶原蛋白:CAS号9007-34-5,上海源叶生物科技有限公司。Type I collagen: CAS No. 9007-34-5, Shanghai Yuanye Biotechnology Co., Ltd.
透明质酸:CAS号9004-61-9,上海邦成化工有限公司。Hyaluronic acid: CAS No. 9004-61-9, Shanghai Bangcheng Chemical Co., Ltd.
麦芽糊精:CAS号9050-36-6,西亚化学科技(山东)有限公司。具有良好的化学稳定性和生物相容性。Maltodextrin: CAS No. 9050-36-6, West Asia Chemical Technology (Shandong) Co., Ltd. It has good chemical stability and biocompatibility.
维生素C:具有抗氧化性。Vitamin C: has antioxidant properties.
2、实施例2. Example
实施例1Example 1
一种丝素蛋白微载体皮肤填充制剂的制备方法,包括以下步骤:A method for preparing a silk fibroin microcarrier skin filling preparation comprises the following steps:
1.1脱胶1.1 Degumming
1.1.1用碱溶液煮沸桑蚕丝30min,过滤,收集沉淀。其中,所述碱溶液为质量分数0.05%的碳酸钠水溶液与质量分数0.03%的L-谷氨酸钠水溶液按照20:1体积比例混合而成的。L-谷氨酸钠对光和热具有一定的稳定性,将其添加到桑蚕丝中进行处理,既能提高丝素蛋白的稳定性,还能够加速脱胶。1.1.1 Boil the silk with an alkaline solution for 30 minutes, filter and collect the precipitate. The alkaline solution is a mixture of a sodium carbonate aqueous solution with a mass fraction of 0.05% and a sodium L-glutamate aqueous solution with a mass fraction of 0.03% in a volume ratio of 20:1. Sodium L-glutamate has a certain stability to light and heat. Adding it to the silk for treatment can not only improve the stability of silk fibroin, but also accelerate degumming.
1.1.2将沉淀继续用1.1.1的碱溶液水溶液煮沸桑蚕丝30min,收集溶液。1.1.2 Continue to boil the precipitate with the alkaline solution in 1.1.1 for 30 minutes and collect the solution.
1.1.3重复步骤1.1.2,直至桑蚕丝脱胶完全,脱胶完全的物料称作丝素蛋白溶液。其中,用苦味酸胭脂红溶液检测是否脱胶完全。1.1.3 Repeat step 1.1.2 until the mulberry silk is completely degummed. The completely degummed material is called silk fibroin solution. Here, the picric acid carmine solution is used to detect whether the degumming is complete.
1.2处理1.2 Processing
1.2.1透析、浓缩与干燥1.2.1 Dialysis, concentration and drying
将1.1.3的丝素蛋白溶液用砂芯漏斗过滤,滤液用乙酸溶液调整pH值至4后用硫酸盐饱和溶液盐析2h,析出沉淀进行离心分离得到蛋白质沉淀。将蛋白质沉淀转移至放有0.2μm孔径的微孔滤膜的砂芯抽滤漏斗中,依次用体积分数75%乙醇和去离子水进行抽滤淋洗。将淋洗后的滤饼超声分散于去离子水中,移入截留分子量为3500Da的透析袋中,透析袋内溶液用体积分数30%的聚乙二醇20000的水溶液进行浓缩。将浓缩液置入冷冻干燥机,在-30℃下进行预冻,冷冻状态下真空干燥10h,得到干燥丝素。The silk protein solution of 1.1.3 was filtered with a sand core funnel, and the filtrate was adjusted to pH 4 with acetic acid solution, and then salted out with a saturated sulfate solution for 2 hours. The precipitate was centrifuged to obtain a protein precipitate. The protein precipitate was transferred to a sand core suction filtration funnel with a microporous filter membrane with a pore size of 0.2 μm, and filtered and washed with 75% ethanol and deionized water by volume. The filter cake after elution was ultrasonically dispersed in deionized water and transferred into a dialysis bag with a molecular weight cutoff of 3500Da. The solution in the dialysis bag was concentrated with a 30% aqueous solution of polyethylene glycol 20000 by volume. The concentrated solution was placed in a freeze dryer, pre-frozen at -30°C, and vacuum dried for 10 hours in a frozen state to obtain dry silk.
1.2.2丝素蛋白的改良:1.2.2 Improvement of silk fibroin:
以双蒸水为溶剂,将1.2.1收集的干燥丝素配置成质量分数5%的水溶液,该水溶液与维生素C按照100:1的质量比例混合,搅拌20min,-20℃冻干,得到VC负载丝素蛋白。Using double distilled water as solvent, the dry silk collected in 1.2.1 was prepared into a 5% aqueous solution by mass, and the aqueous solution was mixed with vitamin C in a mass ratio of 100:1, stirred for 20 minutes, and freeze-dried at -20°C to obtain VC-loaded silk protein.
1.3制备复合凝胶1.3 Preparation of composite gel
以PEG300为溶剂,将1.2.2的VC负载丝素蛋白配置成30g/L的丝素溶液;将丝素溶液、透明质酸、麦芽糊精、辅助因子与交联剂按照10:1:0.5:0.1:0.2的质量比例混合,40℃静置20min,后得到复合凝胶,所述复合凝胶121℃蒸汽灭菌15min,作为丝素蛋白微载体皮肤填充制剂使用,生物相容性好,填充效果好。Using PEG300 as solvent, 1.2.2 VC-loaded silk fibroin was configured into a 30 g/L silk fibroin solution; the silk fibroin solution, hyaluronic acid, maltodextrin, auxiliary factors and cross-linking agent were mixed in a mass ratio of 10:1:0.5:0.1:0.2, and allowed to stand at 40°C for 20 min to obtain a composite gel. The composite gel was steam sterilized at 121°C for 15 min and used as a silk fibroin microcarrier skin filler preparation with good biocompatibility and good filling effect.
其中,交联剂为浓度15g/L的辛基硫酸钠水溶液。辅助因子为维生素B5。The cross-linking agent is a sodium octyl sulfate aqueous solution with a concentration of 15 g/L, and the auxiliary factor is vitamin B5.
实施例2Example 2
一种丝素蛋白微载体皮肤填充制剂的制备方法,包括以下步骤:A method for preparing a silk fibroin microcarrier skin filling preparation comprises the following steps:
1.1脱胶1.1 Degumming
1.1.1用碱溶液煮沸桑蚕丝30min,过滤,收集沉淀。其中,所述碱溶液为质量分数0.05%的碳酸钠水溶液与质量分数0.03%的L-谷氨酸钠水溶液按照20:1体积比例混合而成的。1.1.1 Boil the silk with an alkaline solution for 30 minutes, filter and collect the precipitate. The alkaline solution is a mixture of a 0.05% sodium carbonate aqueous solution and a 0.03% sodium L-glutamate aqueous solution in a volume ratio of 20:1.
1.1.2将沉淀继续用1.1.1的碱溶液水溶液煮沸桑蚕丝30min,收集溶液。1.1.2 Continue to boil the precipitate with the alkaline solution in 1.1.1 for 30 minutes and collect the solution.
1.1.3重复步骤1.1.2,直至桑蚕丝脱胶完全,脱胶完全的物料称作丝素蛋白溶液。其中,用苦味酸胭脂红溶液检测是否脱胶完全。1.1.3 Repeat step 1.1.2 until the mulberry silk is completely degummed. The completely degummed material is called silk fibroin solution. Here, the picric acid carmine solution is used to detect whether the degumming is complete.
1.2处理1.2 Processing
1.2.1透析、浓缩与干燥1.2.1 Dialysis, concentration and drying
将1.1.3的丝素蛋白溶液用砂芯漏斗过滤,滤液用乙酸溶液调整pH值至4后用硫酸盐饱和溶液盐析2h,析出沉淀进行离心分离得到蛋白质沉淀。将蛋白质沉淀转移至放有0.2μm孔径的微孔滤膜的砂芯抽滤漏斗中,依次用体积分数75%乙醇和去离子水进行抽滤淋洗。将淋洗后的滤饼超声分散于去离子水中,移入截留分子量为3500Da的透析袋中,透析袋内溶液用体积分数30%的聚乙二醇20000的水溶液进行浓缩。将浓缩液置入冷冻干燥机,在-30℃下进行预冻,冷冻状态下真空干燥10h,得到干燥丝素。The silk protein solution of 1.1.3 was filtered with a sand core funnel, and the filtrate was adjusted to pH 4 with acetic acid solution, and then salted out with a saturated sulfate solution for 2 hours. The precipitate was centrifuged to obtain a protein precipitate. The protein precipitate was transferred to a sand core suction filtration funnel with a microporous filter membrane with a pore size of 0.2 μm, and filtered and washed with 75% ethanol and deionized water by volume. The filter cake after elution was ultrasonically dispersed in deionized water and transferred into a dialysis bag with a molecular weight cutoff of 3500Da. The solution in the dialysis bag was concentrated with a 30% aqueous solution of polyethylene glycol 20000 by volume. The concentrated solution was placed in a freeze dryer, pre-frozen at -30°C, and vacuum dried for 10 hours in a frozen state to obtain dry silk.
1.2.2丝素蛋白的改良:1.2.2 Improvement of silk fibroin:
以双蒸水为溶剂,将1.2.1收集的干燥丝素配置成质量分数5%的水溶液,该水溶液与维生素C按照90:1的质量比例混合,搅拌20min,-20℃冻干,得到VC负载丝素蛋白。Using double distilled water as solvent, the dry silk collected in 1.2.1 was prepared into a 5% aqueous solution by mass, and the aqueous solution was mixed with vitamin C in a mass ratio of 90:1, stirred for 20 minutes, and freeze-dried at -20°C to obtain VC-loaded silk protein.
1.3制备复合凝胶1.3 Preparation of composite gel
以PEG300为溶剂,将1.2.2的VC负载丝素蛋白配置成30g/L的丝素水溶液,将丝素水溶液、透明质酸、麦芽糊精、辅助因子与交联剂按照10:1:0.5:0.1:0.2的质量比例混合,40℃静置20min,后得到复合凝胶,所述复合凝胶121℃蒸汽灭菌15min,作为丝素蛋白微载体皮肤填充制剂使用,生物相容性好,填充效果好。Using PEG300 as solvent, 1.2.2 VC-loaded silk fibroin was configured into 30 g/L silk fibroin aqueous solution, and the silk fibroin aqueous solution, hyaluronic acid, maltodextrin, auxiliary factors and cross-linking agent were mixed in a mass ratio of 10:1:0.5:0.1:0.2, and allowed to stand at 40°C for 20 min to obtain a composite gel. The composite gel was steam sterilized at 121°C for 15 min and used as a silk fibroin microcarrier skin filling preparation with good biocompatibility and good filling effect.
其中,交联剂为15g/L浓度的辛基硫酸钠溶液。辅助因子为维生素B5。The cross-linking agent is a 15 g/L sodium octyl sulfate solution, and the auxiliary factor is vitamin B5.
实施例3Example 3
一种丝素蛋白微载体皮肤填充制剂的制备方法,包括以下步骤:A method for preparing a silk fibroin microcarrier skin filling preparation comprises the following steps:
1.1脱胶1.1 Degumming
1.1.1用碱溶液煮沸桑蚕丝30min,过滤,收集沉淀。其中,所述碱溶液为质量分数0.05%的碳酸钠水溶液与质量分数0.03%的L-谷氨酸钠水溶液按照20:1体积比例混合而成的。L-谷氨酸钠对光和热具有一定的稳定性,将其添加到桑蚕丝中进行处理,既能提高丝素蛋白的稳定性,还能够加速脱胶。1.1.1 Boil the silk with an alkaline solution for 30 minutes, filter and collect the precipitate. The alkaline solution is a mixture of a sodium carbonate aqueous solution with a mass fraction of 0.05% and a sodium L-glutamate aqueous solution with a mass fraction of 0.03% in a volume ratio of 20:1. Sodium L-glutamate has a certain stability to light and heat. Adding it to the silk for treatment can not only improve the stability of silk fibroin, but also accelerate degumming.
1.1.2将沉淀继续用1.1.1的碱溶液水溶液煮沸桑蚕丝30min,收集沉淀溶液。1.1.2 Continue to boil the precipitate with the alkaline solution in 1.1.1 for 30 minutes and collect the precipitate solution.
1.1.3重复步骤1.1.2,直至桑蚕丝脱胶完全,脱胶完全的物料称作丝素蛋白溶液。其中,用苦味酸胭脂红溶液检测是否脱胶完全。1.1.3 Repeat step 1.1.2 until the mulberry silk is completely degummed. The completely degummed material is called silk fibroin solution. Here, the picric acid carmine solution is used to detect whether the degumming is complete.
1.2.1透析、浓缩与干燥1.2.1 Dialysis, concentration and drying
将1.1.3的丝素蛋白溶液用砂芯漏斗过滤,滤液用乙酸溶液调整pH值至4后用硫酸盐饱和溶液盐析2h,析出沉淀进行离心分离得到蛋白质沉淀。将蛋白质沉淀转移至放有0.2μm孔径的微孔滤膜的砂芯抽滤漏斗中,依次用体积分数75%乙醇和去离子水进行抽滤淋洗。将淋洗后的滤饼超声分散于去离子水中,移入截留分子量为3500Da的透析袋中,透析袋内溶液用体积分数30%的聚乙二醇20000的水溶液进行浓缩。将浓缩液置入冷冻干燥机,在-30℃下进行预冻,冷冻状态下真空干燥10h,得到干燥丝素。The silk protein solution of 1.1.3 was filtered with a sand core funnel, and the filtrate was adjusted to pH 4 with acetic acid solution, and then salted out with a saturated sulfate solution for 2 hours. The precipitate was centrifuged to obtain a protein precipitate. The protein precipitate was transferred to a sand core suction filtration funnel with a microporous filter membrane with a pore size of 0.2 μm, and filtered and washed with 75% ethanol and deionized water by volume. The filter cake after elution was ultrasonically dispersed in deionized water and transferred into a dialysis bag with a molecular weight cutoff of 3500Da. The solution in the dialysis bag was concentrated with a 30% aqueous solution of polyethylene glycol 20000 by volume. The concentrated solution was placed in a freeze dryer, pre-frozen at -30°C, and vacuum dried for 10 hours in a frozen state to obtain dry silk.
1.2.2丝素蛋白的改良:1.2.2 Improvement of silk fibroin:
以双蒸水为溶剂,将1.2.1收集的干燥丝素配置成质量分数5%的水溶液,该水溶液与维生素C按照110:1的质量比例混合,搅拌20min,-20℃冻干,得到VC负载丝素蛋白。Using double distilled water as solvent, the dry silk collected in 1.2.1 was prepared into a 5% aqueous solution by mass, and the aqueous solution was mixed with vitamin C in a mass ratio of 110:1, stirred for 20 minutes, and freeze-dried at -20°C to obtain VC-loaded silk protein.
1.3制备复合凝胶1.3 Preparation of composite gel
以PEG300为溶剂,将1.2.2的VC负载丝素蛋白配置成30g/L的丝素溶液,将丝素溶液、透明质酸、麦芽糊精、辅助因子与交联剂按照10:1:0.5:0.1:0.2的质量比例混合,40℃静置20min,后得到复合凝胶,所述复合凝胶121℃蒸汽灭菌15min,作为丝素蛋白微载体皮肤填充制剂使用,生物相容性好,填充效果好。Using PEG300 as solvent, 1.2.2 VC-loaded silk fibroin was configured into a 30 g/L silk fibroin solution. The silk fibroin solution, hyaluronic acid, maltodextrin, auxiliary factors and cross-linking agent were mixed in a mass ratio of 10:1:0.5:0.1:0.2, and the mixture was allowed to stand at 40°C for 20 min to obtain a composite gel. The composite gel was steam sterilized at 121°C for 15 min and used as a silk fibroin microcarrier skin filler preparation with good biocompatibility and filling effect.
其中,交联剂为15g/L浓度的辛基硫酸钠溶液。辅助因子为维生素B5。The cross-linking agent is a 15 g/L sodium octyl sulfate solution, and the auxiliary factor is vitamin B5.
实施例4Example 4
一种丝素蛋白微载体皮肤填充制剂的制备方法,包括以下步骤:A method for preparing a silk fibroin microcarrier skin filling preparation comprises the following steps:
1.1脱胶1.1 Degumming
1.1.1用碱溶液煮沸桑蚕丝30min,过滤,收集沉淀。其中,所述碱溶液为质量分数0.05%的碳酸钠水溶液与质量分数0.03%的L-谷氨酸钠水溶液按照20:1体积比例混合而成的。L-谷氨酸钠对光和热具有一定的稳定性,将其添加到桑蚕丝中进行处理,既能提高丝素蛋白的稳定性,还能够加速脱胶。1.1.1 Boil the silk with an alkaline solution for 30 minutes, filter and collect the precipitate. The alkaline solution is a mixture of a sodium carbonate aqueous solution with a mass fraction of 0.05% and a sodium L-glutamate aqueous solution with a mass fraction of 0.03% in a volume ratio of 20:1. Sodium L-glutamate has a certain stability to light and heat. Adding it to the silk for treatment can not only improve the stability of silk fibroin, but also accelerate degumming.
1.1.2将沉淀继续用1.1.1的碱溶液水溶液煮沸桑蚕丝30min,收集溶液。1.1.2 Continue to boil the precipitate with the alkaline solution in 1.1.1 for 30 minutes and collect the solution.
1.1.3重复步骤1.1.2,直至桑蚕丝脱胶完全,脱胶完全的物料称作丝素蛋白溶液。其中,用苦味酸胭脂红溶液检测是否脱胶完全。1.1.3 Repeat step 1.1.2 until the mulberry silk is completely degummed. The completely degummed material is called silk fibroin solution. Here, the picric acid carmine solution is used to detect whether the degumming is complete.
1.2处理1.2 Processing
1.2.1透析、浓缩与干燥1.2.1 Dialysis, concentration and drying
将1.1.3的丝素蛋白溶液用砂芯漏斗过滤,滤液用乙酸溶液调整pH值至4后用硫酸盐饱和溶液盐析2h,析出沉淀进行离心分离得到蛋白质沉淀。将蛋白质沉淀转移至放有0.2μm孔径的微孔滤膜的砂芯抽滤漏斗中,依次用75%乙醇和去离子水进行抽滤淋洗。将淋洗后的滤饼超声分散于去离子水中,移入截留分子量为3500Da的透析袋中,透析袋内溶液用体积分数30%的聚乙二醇20000的水溶液进行浓缩。将浓缩液置入冷冻干燥机,在-30℃下进行预冻,冷冻状态下真空干燥10h,得到干燥丝素。The silk protein solution of 1.1.3 was filtered with a sand core funnel, and the filtrate was adjusted to pH 4 with acetic acid solution, and then salted out with a saturated sulfate solution for 2 hours. The precipitate was centrifuged to obtain a protein precipitate. The protein precipitate was transferred to a sand core suction filtration funnel with a microporous filter membrane with a pore size of 0.2 μm, and filtered and washed with 75% ethanol and deionized water in turn. The filter cake after elution was ultrasonically dispersed in deionized water and transferred into a dialysis bag with a molecular weight cutoff of 3500Da. The solution in the dialysis bag was concentrated with a 30% volume fraction of polyethylene glycol 20000 aqueous solution. The concentrated solution was placed in a freeze dryer, pre-frozen at -30°C, and vacuum dried for 10 hours in a frozen state to obtain dry silk.
1.2.2丝素蛋白的改良:1.2.2 Improvement of silk fibroin:
以双蒸水为溶剂,将1.2.1收集的干燥丝素配置成质量分数5%的水溶液,该水溶液与维生素C按照100:1的质量比例混合,搅拌20min,-20℃冻干,得到VC负载丝素蛋白。1.3制备复合凝胶。Using double distilled water as solvent, the dried silk collected in 1.2.1 was prepared into a 5% aqueous solution, the aqueous solution was mixed with vitamin C in a mass ratio of 100:1, stirred for 20 minutes, and freeze-dried at -20°C to obtain VC-loaded silk protein. 1.3 Preparation of composite gel.
以PEG300为溶剂,将1.2.2的VC负载丝素蛋白配置成30g/L的丝素溶液,将丝素溶液、透明质酸、麦芽糊精、辅助因子与交联剂按照10:1:0.6:0.1:0.2的质量比例混合,40℃静置20min,后得到复合凝胶,所述复合凝胶121℃蒸汽灭菌15min,作为丝素蛋白微载体皮肤填充制剂使用,生物相容性好,填充效果好。Using PEG300 as solvent, 1.2.2 VC-loaded silk fibroin was prepared into 30 g/L silk fibroin solution, and the silk solution, hyaluronic acid, maltodextrin, auxiliary factors and cross-linking agent were mixed in a mass ratio of 10:1:0.6:0.1:0.2, and allowed to stand at 40°C for 20 min to obtain a composite gel. The composite gel was steam sterilized at 121°C for 15 min and used as a silk fibroin microcarrier skin filler preparation with good biocompatibility and good filling effect.
其中,交联剂为15g/L浓度的辛基硫酸钠溶液。辅助因子为维生素B5。The cross-linking agent is a 15 g/L sodium octyl sulfate solution, and the auxiliary factor is vitamin B5.
实施例5Example 5
一种丝素蛋白微载体皮肤填充制剂的制备方法,包括以下步骤:A method for preparing a silk fibroin microcarrier skin filling preparation comprises the following steps:
1.1脱胶1.1 Degumming
1.1.1用碱溶液煮沸桑蚕丝30min,过滤,收集沉淀。其中,所述碱溶液为质量分数0.05%的碳酸钠水溶液与质量分数0.03%的L-谷氨酸钠水溶液按照20:1体积比例混合而成的。L-谷氨酸钠对光和热具有一定的稳定性,将其添加到桑蚕丝中进行处理,既能提高丝素蛋白的稳定性,还能够加速脱胶。1.1.1 Boil the silk with an alkaline solution for 30 minutes, filter and collect the precipitate. The alkaline solution is a mixture of a sodium carbonate aqueous solution with a mass fraction of 0.05% and a sodium L-glutamate aqueous solution with a mass fraction of 0.03% in a volume ratio of 20:1. Sodium L-glutamate has a certain stability to light and heat. Adding it to the silk for treatment can not only improve the stability of silk fibroin, but also accelerate degumming.
1.1.2将沉淀继续用1.1.1的碱溶液水溶液煮沸桑蚕丝30min,收集溶液。1.1.2 Continue to boil the precipitate with the alkaline solution in 1.1.1 for 30 minutes and collect the solution.
1.1.3重复步骤1.1.2,直至桑蚕丝脱胶完全,脱胶完全的物料称作丝素蛋白溶液。其中,用苦味酸胭脂红溶液检测是否脱胶完全。1.1.3 Repeat step 1.1.2 until the mulberry silk is completely degummed. The completely degummed material is called silk fibroin solution. Here, the picric acid carmine solution is used to detect whether the degumming is complete.
1.2处理1.2 Processing
1.2.1透析、浓缩与干燥1.2.1 Dialysis, concentration and drying
将1.1.3的丝素蛋白溶液用砂芯漏斗过滤,滤液用乙酸溶液调整pH值至4后用硫酸盐饱和溶液盐析2h,析出沉淀进行离心分离得到蛋白质沉淀。将蛋白质沉淀转移至放有0.2μm孔径的微孔滤膜的砂芯抽滤漏斗中,依次用体积分数75%乙醇和去离子水进行抽滤淋洗。将淋洗后的滤饼超声分散于去离子水中,移入截留分子量为3500Da的透析袋中,透析袋内溶液用体积分数30%的聚乙二醇20000的水溶液进行浓缩。将浓缩液置入冷冻干燥机,在-30℃下进行预冻,冷冻状态下真空干燥10h,得到干燥丝素。The silk protein solution of 1.1.3 was filtered with a sand core funnel, and the filtrate was adjusted to pH 4 with acetic acid solution, and then salted out with a saturated sulfate solution for 2 hours. The precipitate was centrifuged to obtain a protein precipitate. The protein precipitate was transferred to a sand core suction filtration funnel with a microporous filter membrane with a pore size of 0.2 μm, and filtered and washed with 75% ethanol and deionized water by volume. The filter cake after elution was ultrasonically dispersed in deionized water and transferred into a dialysis bag with a molecular weight cutoff of 3500Da. The solution in the dialysis bag was concentrated with a 30% aqueous solution of polyethylene glycol 20000 by volume. The concentrated solution was placed in a freeze dryer, pre-frozen at -30°C, and vacuum dried for 10 hours in a frozen state to obtain dry silk.
1.2.2丝素蛋白的改良:1.2.2 Improvement of silk fibroin:
以双蒸水为溶剂,将1.2.1收集的干燥丝素配置成质量分数5%的水溶液,该水溶液与维生素C按照100:1的质量比例混合,搅拌20min,-20℃冻干,得到VC负载丝素蛋白。Using double distilled water as solvent, the dry silk collected in 1.2.1 was prepared into a 5% aqueous solution by mass, and the aqueous solution was mixed with vitamin C in a mass ratio of 100:1, stirred for 20 minutes, and freeze-dried at -20°C to obtain VC-loaded silk protein.
1.3制备复合凝胶1.3 Preparation of composite gel
以PEG300为溶剂,将1.2.2的VC负载丝素蛋白配置成30g/L的丝素溶液,将丝素溶液、透明质酸、麦芽糊精、辅助因子与交联剂按照10:1:0.7:0.1:1的质量比例混合,40℃静置20min,后得到复合凝胶,所述复合凝胶121℃蒸汽灭菌15min,作为丝素蛋白微载体皮肤填充制剂使用,生物相容性好,填充效果好。Using PEG300 as solvent, 1.2.2 VC-loaded silk fibroin was configured into a 30 g/L silk fibroin solution. The silk fibroin solution, hyaluronic acid, maltodextrin, auxiliary factors and cross-linking agent were mixed in a mass ratio of 10:1:0.7:0.1:1, and the mixture was allowed to stand at 40°C for 20 min to obtain a composite gel. The composite gel was steam sterilized at 121°C for 15 min and used as a silk fibroin microcarrier skin filler preparation with good biocompatibility and filling effect.
其中,交联剂为15g/L浓度的辛基硫酸钠溶液。辅助因子为维生素B5。The cross-linking agent is a 15 g/L sodium octyl sulfate solution, and the auxiliary factor is vitamin B5.
实施例6Example 6
一种丝素蛋白微载体皮肤填充制剂的制备方法,包括以下步骤:A method for preparing a silk fibroin microcarrier skin filling preparation comprises the following steps:
1.1脱胶1.1 Degumming
1.1.1用碱溶液煮沸桑蚕丝30min,过滤,收集沉淀。其中,所述碱溶液为质量分数0.05%的碳酸钠水溶液与质量分数0.03%的L-谷氨酸钠水溶液按照20:1体积比例混合而成的。L-谷氨酸钠对光和热具有一定的稳定性,将其添加到桑蚕丝中进行处理,既能提高丝素蛋白的稳定性,还能够加速脱胶。1.1.1 Boil the silk with an alkaline solution for 30 minutes, filter and collect the precipitate. The alkaline solution is a mixture of a sodium carbonate aqueous solution with a mass fraction of 0.05% and a sodium L-glutamate aqueous solution with a mass fraction of 0.03% in a volume ratio of 20:1. Sodium L-glutamate has a certain stability to light and heat. Adding it to the silk for treatment can not only improve the stability of silk fibroin, but also accelerate degumming.
1.1.2将沉淀继续用1.1.1的碱溶液水溶液煮沸桑蚕丝30min,收集溶液。1.1.2 Continue to boil the precipitate with the alkaline solution in 1.1.1 for 30 minutes and collect the solution.
1.1.3重复步骤1.1.2,直至桑蚕丝脱胶完全,脱胶完全的物料称作丝素蛋白溶液。其中,用苦味酸胭脂红溶液检测是否脱胶完全。1.1.3 Repeat step 1.1.2 until the mulberry silk is completely degummed. The completely degummed material is called silk fibroin solution. Here, the picric acid carmine solution is used to detect whether the degumming is complete.
1.2处理1.2 Processing
1.2.1透析、浓缩与干燥1.2.1 Dialysis, concentration and drying
将1.1.3的丝素蛋白溶液用砂芯漏斗过滤,滤液用乙酸溶液调整pH值至4后用硫酸盐饱和溶液盐析2h,析出沉淀进行离心分离得到蛋白质沉淀。将蛋白质沉淀转移至放有0.2μm孔径的微孔滤膜的砂芯抽滤漏斗中,依次用75%乙醇和去离子水进行抽滤淋洗。将淋洗后的滤饼超声分散于去离子水中,移入截留分子量为3500Da的透析袋中,透析袋内溶液用体积分数30%的聚乙二醇20000的水溶液进行浓缩。将浓缩液置入冷冻干燥机,在-30℃下进行预冻,冷冻状态下真空干燥10h,得到干燥丝素。The silk protein solution of 1.1.3 was filtered with a sand core funnel, and the filtrate was adjusted to pH 4 with acetic acid solution, and then salted out with a saturated sulfate solution for 2 hours. The precipitate was centrifuged to obtain a protein precipitate. The protein precipitate was transferred to a sand core suction filtration funnel with a microporous filter membrane with a pore size of 0.2 μm, and filtered and washed with 75% ethanol and deionized water in turn. The filter cake after elution was ultrasonically dispersed in deionized water and transferred into a dialysis bag with a molecular weight cutoff of 3500Da. The solution in the dialysis bag was concentrated with a 30% volume fraction of polyethylene glycol 20000 aqueous solution. The concentrated solution was placed in a freeze dryer, pre-frozen at -30°C, and vacuum dried for 10 hours in a frozen state to obtain dry silk.
1.2.2丝素蛋白的改良:1.2.2 Improvement of silk fibroin:
以双蒸水为溶剂,将1.2.1收集的干燥丝素配置成质量分数5%的水溶液,该水溶液与维生素C按照100:1的质量比例混合,搅拌20min,-20℃冻干,得到VC负载丝素蛋白。Using double distilled water as solvent, the dry silk collected in 1.2.1 was prepared into a 5% aqueous solution by mass, and the aqueous solution was mixed with vitamin C in a mass ratio of 100:1, stirred for 20 minutes, and freeze-dried at -20°C to obtain VC-loaded silk protein.
1.3制备复合凝胶1.3 Preparation of composite gel
以PEG300为溶剂,将1.2.2的VC负载丝素蛋白配置成30g/L的丝素溶液,将丝素溶液、透明质酸、麦芽糊精、辅助因子与交联剂按照10:1:0.8:0.1:1的质量比例混合,40℃静置20min,后得到复合凝胶,所述复合凝胶121℃蒸汽灭菌15min,作为丝素蛋白微载体皮肤填充制剂使用,生物相容性好,填充效果好。Using PEG300 as solvent, 1.2.2 VC-loaded silk fibroin was configured into a 30 g/L silk fibroin solution. The silk fibroin solution, hyaluronic acid, maltodextrin, auxiliary factors and cross-linking agent were mixed in a mass ratio of 10:1:0.8:0.1:1, and the mixture was allowed to stand at 40°C for 20 min to obtain a composite gel. The composite gel was steam sterilized at 121°C for 15 min and used as a silk fibroin microcarrier skin filler preparation with good biocompatibility and filling effect.
其中,交联剂为15g/L浓度的辛基硫酸钠溶液。辅助因子为维生素B5。The cross-linking agent is a 15 g/L sodium octyl sulfate solution, and the auxiliary factor is vitamin B5.
以上实施例制备的丝素蛋白微载体皮肤填充制剂的抗酶效果好,生物相容性好。The silk fibroin microcarrier skin filling preparation prepared in the above examples has good anti-enzyme effect and good biocompatibility.
3、本发明的创新点的说明3. Description of the innovative features of the present invention
(1)创新点1:本发明采用改进的碱溶液配方,提高脱胶效率,缩短脱胶时间。不同方法设计如下:(1) Innovation 1: The present invention adopts an improved alkaline solution formula to improve degumming efficiency and shorten degumming time. Different methods are designed as follows:
试验1-1:用碱溶液煮沸桑蚕丝30min,过滤,收集沉淀。其中,所述碱溶液为质量分数0.05%的碳酸钠水溶液与质量分数0.03%的L-谷氨酸钠水溶液按照20:1体积比例混合而成的。将沉淀继续用所述碱溶液水溶液煮沸桑蚕丝30min,检测是否脱胶完全。重复步骤“用所述碱溶液水溶液煮沸桑蚕丝30min,检测是否脱胶完全”直至桑蚕丝脱胶完全。Test 1-1: Boil the silk with an alkaline solution for 30 minutes, filter and collect the precipitate. The alkaline solution is a mixture of a sodium carbonate aqueous solution with a mass fraction of 0.05% and a sodium L-glutamate aqueous solution with a mass fraction of 0.03% in a volume ratio of 20:1. Boil the precipitate with the alkaline solution for another 30 minutes to check whether the degumming is complete. Repeat the step of "boil the silk with the alkaline solution for 30 minutes to check whether the degumming is complete" until the silk is completely degummed.
试验1-2:与试验1-1的操作基本相同,区别在于将碱溶液改为质量分数0.05%的碳酸钠水溶液。Experiment 1-2: The operation is basically the same as that of Experiment 1-1, except that the alkaline solution is replaced by a sodium carbonate aqueous solution with a mass fraction of 0.05%.
本试验中,用苦味酸胭脂红溶液检测是否脱胶完全。不同方法的脱胶时间的对比结果参见表1。其中,现有技术的质量分数0.05%的碳酸钠水溶液作为对照组。In this test, picric acid carmine solution was used to detect whether the degumming was complete. The comparison results of degumming time of different methods are shown in Table 1. Among them, the sodium carbonate aqueous solution with a mass fraction of 0.05% in the prior art was used as the control group.
表1不同方法的脱胶时间的对比结果Table 1 Comparison results of degumming time of different methods
注:表1中,效率提高率是以试验1-2的时间为对照计算的,故“-”的含义是不计算试验1-2的效率提高率。Note: In Table 1, the efficiency improvement rate is calculated based on the time of Test 1-2, so the meaning of “-” is that the efficiency improvement rate of Test 1-2 is not calculated.
表1的结果显示,使用碳酸钠水溶液与L-谷氨酸钠水溶液的混合液煮沸桑蚕丝脱胶时间最短。所以我们还探究了不同0.05%碳酸钠水溶液与0.03%L-谷氨酸钠水溶液的脱胶时间,以期获得最佳的比例。结果参见表2。The results in Table 1 show that the degumming time of mulberry silk is the shortest when the mixture of sodium carbonate aqueous solution and sodium L-glutamate aqueous solution is boiled. Therefore, we also explored the degumming time of different 0.05% sodium carbonate aqueous solution and 0.03% sodium L-glutamate aqueous solution in order to obtain the best ratio. The results are shown in Table 2.
表2不同碳酸钠水溶液与L-谷氨酸钠水溶液的脱胶时间Table 2 Degumming time of different sodium carbonate aqueous solutions and sodium L-glutamate aqueous solutions
表2结果显示,随着碳酸钠用量的逐渐减少,脱胶时间呈现先降低后增高的趋势,其中,当碳酸钠水溶液与L-谷氨酸钠水溶液为10-30:1的范围内时,脱胶时间较短,利于节约时间成本。The results in Table 2 show that as the amount of sodium carbonate is gradually reduced, the degumming time shows a trend of first decreasing and then increasing. Among them, when the ratio of the sodium carbonate aqueous solution to the L-sodium glutamate aqueous solution is in the range of 10-30:1, the degumming time is shorter, which is beneficial to saving time cost.
(2)创新点2:通过对丝素蛋白进行改良,提高抗酶解能力。试验设置如下。(2) Innovation 2: Improving the ability to resist enzymatic degradation by improving silk fibroin. The experimental setup is as follows.
试验2-1:采用实施例1的方法制备脱胶完全的干燥丝素。以双蒸水为溶剂,将干燥丝素配置成质量分数5%的水溶液,该水溶液与维生素C按照100:1的质量比例混合,搅拌20min,-20℃冻干,得到VC负载丝素蛋白;以PEG300为溶剂,将VC负载丝素蛋白配置成30g/L的丝素溶液,将丝素溶液、透明质酸、麦芽糊精、辅助因子与交联剂按照10:1:0.5:0.1:0.2的质量比例混合,40℃静置20min,后得到复合凝胶。交联剂为15g/L的辛基硫酸钠水溶液。辅助因子为维生素B5。Experiment 2-1: The method of Example 1 was used to prepare completely degummed dry silk fibroin. Double distilled water was used as solvent to prepare dry silk fibroin into an aqueous solution with a mass fraction of 5%, and the aqueous solution was mixed with vitamin C in a mass ratio of 100:1, stirred for 20 minutes, and freeze-dried at -20°C to obtain VC-loaded silk fibroin protein; PEG300 was used as solvent to prepare VC-loaded silk fibroin protein into a 30g/L silk fibroin solution, and the silk fibroin solution, hyaluronic acid, maltodextrin, auxiliary factor and cross-linking agent were mixed in a mass ratio of 10:1:0.5:0.1:0.2, and allowed to stand at 40°C for 20 minutes to obtain a composite gel. The cross-linking agent was a 15g/L sodium octyl sulfate aqueous solution. The auxiliary factor was vitamin B5.
试验2-2:采用实施例1的方法制备脱胶完全的干燥丝素。以PEG300为溶剂,将干燥丝素配置成30g/L的丝素溶液,将丝素溶液、透明质酸、麦芽糊精、辅助因子与交联剂按照10:1:0.5:0.1:0.2的质量比例混合,40℃静置20min,后得到复合凝胶。交联剂为15g/L的辛基硫酸钠水溶液。辅助因子为维生素B5。Experiment 2-2: The method of Example 1 was used to prepare completely degummed dry silk. PEG300 was used as solvent to prepare a 30 g/L silk solution. The silk solution, hyaluronic acid, maltodextrin, auxiliary factor and cross-linking agent were mixed in a mass ratio of 10:1:0.5:0.1:0.2, and allowed to stand at 40°C for 20 min to obtain a composite gel. The cross-linking agent was a 15 g/L sodium octyl sulfate aqueous solution. The auxiliary factor was vitamin B5.
试验方法如下:透明质酸被透明质酸酶酶解后,可产生葡萄糖醛酸,通过测试透明质酸酶酶解前后的葡萄糖醛酸浓度,即可判断复合凝胶的抗酶解能力。The test method is as follows: after hyaluronic acid is hydrolyzed by hyaluronidase, glucuronic acid can be produced. By testing the glucuronic acid concentration before and after hyaluronidase hydrolysis, the anti-enzymatic ability of the composite gel can be determined.
不同丝素蛋白处理方式制备的复合凝胶的体外酶解实验结果参见表3。The results of in vitro enzymatic hydrolysis experiments of composite gels prepared by different silk fibroin treatment methods are shown in Table 3.
表3不同丝素蛋白处理方式制备的复合凝胶的体外酶解实验结果Table 3 Results of in vitro enzymatic hydrolysis experiments of composite gels prepared by different silk fibroin treatment methods
表3的结果显示,试验2-1酶解后葡萄糖醛酸浓度低于试验2-2,说明添加VC以后,抗酶解效果更好。The results in Table 3 show that the glucuronic acid concentration after enzymatic hydrolysis in Test 2-1 is lower than that in Test 2-2, indicating that the anti-enzymatic hydrolysis effect is better after adding VC.
我们还探究了混合液中不同VC用量对复合凝胶体外抗酶解性能的影响(试验2-1的方法更改了水溶液与维生素C的比例),结果参见表4。We also investigated the effect of different VC dosages in the mixed solution on the in vitro anti-enzymatic performance of the composite gel (the method of experiment 2-1 changed the ratio of aqueous solution to vitamin C). The results are shown in Table 4.
表4同VC用量对复合凝胶体外抗酶解性能的影响Table 4 Effect of VC dosage on the in vitro anti-enzymatic performance of composite gel
表4结果显示,在复合凝胶的体系条件下,随着VC加入量的逐渐增多,抗酶解性能呈现先增高后趋于平稳的趋势,说明VC对于复合凝胶体系的抗酶解能力有强化效果。The results in Table 4 show that under the system conditions of the composite gel, with the gradual increase in the amount of VC added, the anti-enzymatic performance shows a trend of first increasing and then tending to be stable, indicating that VC has a strengthening effect on the anti-enzymatic ability of the composite gel system.
(3)创新点3:麦芽糊精与改良的丝素蛋白溶液组合使用,制成的复合凝胶抗酶解效果和辅助因子负载性能均更好。(3) Innovation point 3: The composite gel prepared by combining maltodextrin with modified silk fibroin solution has better anti-enzymatic effect and auxiliary factor loading performance.
1)复合凝胶抗酶解效果试验1) Test on the anti-enzymatic effect of composite gel
不同方法设计如下:The different methods are designed as follows:
试验3-1:采用实施例1的方法制备脱胶完全的干燥丝素。以双蒸水为溶剂,将干燥丝素配置成质量分数5%的水溶液,该水溶液与维生素C按照100:1的质量比例混合,搅拌20min,-20℃冻干,得到VC负载丝素蛋白;以PEG300为溶剂,将VC负载丝素蛋白配置成30g/L的丝素溶液,将丝素溶液、透明质酸、麦芽糊精、辅助因子与交联剂按照10:1:0.5:0.1:0.2的质量比例混合,40℃静置20min,后得到复合凝胶。交联剂为15g/L的辛基硫酸钠水溶液。辅助因子为维生素B5。Experiment 3-1: The method of Example 1 was used to prepare completely degummed dry silk. Using double distilled water as solvent, the dry silk was prepared into an aqueous solution with a mass fraction of 5%, the aqueous solution was mixed with vitamin C in a mass ratio of 100:1, stirred for 20 minutes, and freeze-dried at -20°C to obtain VC-loaded silk protein; using PEG300 as solvent, the VC-loaded silk protein was prepared into a 30g/L silk solution, the silk solution, hyaluronic acid, maltodextrin, auxiliary factor and cross-linking agent were mixed in a mass ratio of 10:1:0.5:0.1:0.2, and allowed to stand at 40°C for 20 minutes to obtain a composite gel. The cross-linking agent was a 15g/L sodium octyl sulfate aqueous solution. The auxiliary factor was vitamin B5.
试验3-2:采用实施例1的方法制备脱胶完全的干燥丝素。以双蒸水为溶剂,将干燥丝素配置成质量分数5%的水溶液,该水溶液与维生素C按照100:1的质量比例混合,搅拌20min,-20℃冻干,得到VC负载丝素蛋白;以PEG300为溶剂,将VC负载丝素蛋白配置成30g/L的丝素溶液,将丝素溶液、透明质酸、辅助因子与交联剂按照10:1:0.1:0.2的质量比例混合,40℃静置20min,后得到复合凝胶。交联剂为15g/L的辛基硫酸钠水溶液。辅助因子为维生素B5。Experiment 3-2: The method of Example 1 was used to prepare completely degummed dry silk. Using double distilled water as solvent, the dry silk was prepared into an aqueous solution with a mass fraction of 5%, and the aqueous solution was mixed with vitamin C in a mass ratio of 100:1, stirred for 20 minutes, and freeze-dried at -20°C to obtain VC-loaded silk protein; using PEG300 as solvent, the VC-loaded silk protein was prepared into a 30g/L silk solution, and the silk solution, hyaluronic acid, auxiliary factor and cross-linking agent were mixed in a mass ratio of 10:1:0.1:0.2, and allowed to stand at 40°C for 20 minutes to obtain a composite gel. The cross-linking agent was a 15g/L sodium octyl sulfate aqueous solution. The auxiliary factor was vitamin B5.
不同处理方法的丝素蛋白微载体皮肤填充制剂复合凝胶体外抗酶解性能对比结果参见表5。The comparison results of the in vitro anti-enzymatic performance of the composite gel of silk fibroin microcarrier skin filling preparations treated by different methods are shown in Table 5.
表5不同方法对复合凝胶体外抗酶解性能的影响Table 5 Effects of different methods on the in vitro anti-enzymatic properties of composite gel
表5结果显示,试验3-1的抗酶解效果更好。The results in Table 5 show that the anti-enzymatic effect of Test 3-1 is better.
我们还探究了不同丝素溶液、透明质酸、麦芽糊精与交联剂比例对复合凝胶体外抗酶解性能的影响,结果参见表6。表6结果显示,10:0.5-0.8:0.1:0.2的范围内,材料的抗酶解性能均较佳。We also explored the effects of different ratios of silk fibroin solution, hyaluronic acid, maltodextrin and cross-linking agent on the in vitro anti-enzymatic performance of the composite gel, and the results are shown in Table 6. The results in Table 6 show that within the range of 10:0.5-0.8:0.1:0.2, the anti-enzymatic performance of the material is better.
表6丝素水溶液、麦芽糊精与交联剂比例对复合凝胶体外抗酶解性能的影响Table 6 Effect of silk fibroin aqueous solution, maltodextrin and cross-linking agent ratio on the in vitro anti-enzymatic properties of composite gel
2)辅助因子负载率试验2) Auxiliary factor loading rate test
试验3-3:采用实施例1的方法制备脱胶完全的干燥丝素。以双蒸水为溶剂,将干燥丝素配置成质量分数5%的水溶液,该水溶液与维生素C按照100:1的质量比例混合,搅拌20min,-20℃冻干,得到VC负载丝素蛋白;以PEG300为溶剂,将VC负载丝素蛋白配置成30g/L的丝素溶液,将丝素溶液、透明质酸、麦芽糊精与交联剂按照10:1:0.5:1的质量比例混合,40℃静置20min,得到复合凝胶。其中,交联剂为15g/L的辛基硫酸钠水溶液。辅助因子为维生素B5。Experiment 3-3: The method of Example 1 was used to prepare completely degummed dry silk. Using double distilled water as solvent, the dry silk was prepared into an aqueous solution with a mass fraction of 5%, the aqueous solution was mixed with vitamin C in a mass ratio of 100:1, stirred for 20 minutes, and freeze-dried at -20°C to obtain VC-loaded silk protein; using PEG300 as solvent, the VC-loaded silk protein was prepared into a 30g/L silk solution, the silk solution, hyaluronic acid, maltodextrin and cross-linking agent were mixed in a mass ratio of 10:1:0.5:1, and allowed to stand at 40°C for 20 minutes to obtain a composite gel. Among them, the cross-linking agent was a 15g/L sodium octyl sulfate aqueous solution. The auxiliary factor was vitamin B5.
试验3-4:采用实施例1的方法制备脱胶完全的干燥丝素。以双蒸水为溶剂,将干燥丝素配置成质量分数5%的水溶液,该水溶液与维生素C按照100:1的质量比例混合,搅拌20min,-20℃冻干,得到VC负载丝素蛋白;以PEG300为溶剂,将VC负载丝素蛋白配置成30g/L的丝素溶液,将丝素溶液、透明质酸与交联剂按照10:1:1的质量比例混合,40℃静置20min,得到复合凝胶。交联剂为15g/L的辛基硫酸钠水溶液。辅助因子为维生素B5。Experiment 3-4: The method of Example 1 was used to prepare completely degummed dry silk. Using double distilled water as solvent, the dry silk was prepared into an aqueous solution with a mass fraction of 5%, the aqueous solution was mixed with vitamin C in a mass ratio of 100:1, stirred for 20 minutes, and freeze-dried at -20°C to obtain VC-loaded silk protein; using PEG300 as solvent, the VC-loaded silk protein was prepared into a 30g/L silk solution, the silk solution, hyaluronic acid and cross-linking agent were mixed in a mass ratio of 10:1:1, and allowed to stand at 40°C for 20 minutes to obtain a composite gel. The cross-linking agent was a 15g/L sodium octyl sulfate aqueous solution. The auxiliary factor was vitamin B5.
本试验探究了对维生素B5的负载率,结果参见表7,结果显示,添加麦芽糊精后,可提高对维生素B5的负载率。This experiment explored the loading rate of vitamin B5. The results are shown in Table 7. The results show that the loading rate of vitamin B5 can be increased after adding maltodextrin.
表7辅助因子负载率试验结果Table 7 Auxiliary factor loading rate test results
4.应用4. Application
我们还进行了填充修复皮肤试验,图1、图2和图3展示了不同受试志愿者的皮肤修复结果,图1、图2和图3中箭头所指是填充区,通过应用实验可知,本发明制备的丝素蛋白微载体皮肤填充制剂更有利于用于修复皮肤。需要说明的是,为保护受试者隐私,图1、图2和图3仅采用了眼部效果图。We also conducted a skin filling and repair test. Figures 1, 2 and 3 show the skin repair results of different volunteers. The arrows in Figures 1, 2 and 3 indicate the filling area. Through the application experiment, it can be seen that the silk fibroin microcarrier skin filling preparation prepared by the present invention is more conducive to skin repair. It should be noted that in order to protect the privacy of the subjects, Figures 1, 2 and 3 only use eye effect pictures.
需要说明的是,本发明中涉及数值范围时,应理解为每个数值范围的两个端点以及两个端点之间任何一个数值均可选用,由于采用的步骤方法与实施例相同,为了防止赘述,本发明描述了优选的实施例。尽管已描述了本发明的优选实施例,但本领域内的技术人员一旦得知了基本创造性概念,则可对这些实施例做出另外的变更和修改。所以,所附权利要求意欲解释为包括优选实施例以及落入本发明范围的所有变更和修改。It should be noted that when the present invention involves a numerical range, it should be understood that the two endpoints of each numerical range and any value between the two endpoints can be selected. Since the steps and methods used are the same as those in the embodiments, in order to avoid redundancy, the present invention describes a preferred embodiment. Although the preferred embodiments of the present invention have been described, those skilled in the art may make additional changes and modifications to these embodiments once they know the basic creative concept. Therefore, the attached claims are intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention.
显然,本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样,倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内,则本发明也意图包含这些改动和变型在内。Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311721348.5A CN117599247B (en) | 2023-12-14 | 2023-12-14 | Silk fibroin microcarrier skin filling preparation, and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311721348.5A CN117599247B (en) | 2023-12-14 | 2023-12-14 | Silk fibroin microcarrier skin filling preparation, and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117599247A CN117599247A (en) | 2024-02-27 |
| CN117599247B true CN117599247B (en) | 2024-05-31 |
Family
ID=89944333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311721348.5A Active CN117599247B (en) | 2023-12-14 | 2023-12-14 | Silk fibroin microcarrier skin filling preparation, and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117599247B (en) |
Citations (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2562415A1 (en) * | 2003-04-10 | 2005-02-10 | Tufts University | Concentrated aqueous silk fibroin solutions free of organic solvents and uses thereof |
| TW200529875A (en) * | 2004-02-03 | 2005-09-16 | Hayashibara Biochem Lab | Cosmetics |
| CN101032683A (en) * | 2006-03-10 | 2007-09-12 | 郑亚津 | Xanthin micro-capsule and the preparing method |
| CN102516777A (en) * | 2011-11-29 | 2012-06-27 | 苏州大学 | Aqueous solution of silk fibroin and preparation method for aqueous solution |
| CN102560888A (en) * | 2012-01-17 | 2012-07-11 | 东华大学 | Silk fibroin nano-fiber film loaded with water-soluble vitamin E and preparation method for nano-fiber film |
| TW201247179A (en) * | 2011-05-30 | 2012-12-01 | Univ Taipei Medical | Polyelectrolyte complex gels and soft tissue augmentation implants comprising the same |
| CN102836465A (en) * | 2012-08-30 | 2012-12-26 | 浙江星月生物科技股份有限公司 | Silk-fibroi and hyaluronic-acid (HA) composite gel for injection and preparation and application thereof |
| CN103469351A (en) * | 2013-07-18 | 2013-12-25 | 嘉兴学院 | Preparation method of vitamin C-loaded silk fibroin/hyaluronic acid composite nanofibers |
| WO2014168433A2 (en) * | 2013-04-09 | 2014-10-16 | Kweon Seong Beom | Material composition for promoting hair growth, gray hair melanin regeneration and skin regeneration |
| CN105688210A (en) * | 2016-03-10 | 2016-06-22 | 陕西瑞凯生物科技有限公司 | Yolk biological protein skin repair dressing and preparation method thereof |
| CN106176281A (en) * | 2016-07-26 | 2016-12-07 | 西安艾尔菲生物科技有限公司 | Carry the fibroin albumen/HA complex microsphere lyophilized powder of active component and preparation and application |
| CN106492279A (en) * | 2016-11-04 | 2017-03-15 | 武汉纺织大学 | A kind of fast preparation method of fibroin albumen hyaluronic acid pluralgel |
| CN108070106A (en) * | 2017-11-22 | 2018-05-25 | 玖久丝绸股份有限公司 | A kind of preparation method of fibroin albumen grafting maltodextrin porous material |
| CN108745216A (en) * | 2018-01-14 | 2018-11-06 | 浙江工商大学 | Preparation method for the silk fibroin powder for making SF-Cd sustained-release micro-spheres |
| IT201700091328A1 (en) * | 2017-08-07 | 2019-02-07 | Leonardino S R L | Electrospun matrix based on silk proteins, process for its preparation, manufactured articles that include it and their use in therapy and in cosmetics |
| CN110237022A (en) * | 2019-07-03 | 2019-09-17 | 斯微(上海) 生物科技有限公司 | A kind of freeze-dried powder, solvent and its application |
| CN111973494A (en) * | 2020-09-22 | 2020-11-24 | 南京飞天一淼科技服务有限公司 | Long-acting moisturizing type moisturizing cream and preparation method thereof |
| CN115463263A (en) * | 2022-08-26 | 2022-12-13 | 上海交通大学医学院附属第九人民医院 | Injectable double-network hydrogel system and preparation method and application thereof |
| CN116966341A (en) * | 2023-08-25 | 2023-10-31 | 杭州雪境医疗器械有限公司 | Preparation method and application of cosmetic filler |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230201414A1 (en) * | 2020-05-28 | 2023-06-29 | University Of Montana | Devices comprising hyaluronic acid and silk fibroin |
-
2023
- 2023-12-14 CN CN202311721348.5A patent/CN117599247B/en active Active
Patent Citations (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2562415A1 (en) * | 2003-04-10 | 2005-02-10 | Tufts University | Concentrated aqueous silk fibroin solutions free of organic solvents and uses thereof |
| TW200529875A (en) * | 2004-02-03 | 2005-09-16 | Hayashibara Biochem Lab | Cosmetics |
| CN101032683A (en) * | 2006-03-10 | 2007-09-12 | 郑亚津 | Xanthin micro-capsule and the preparing method |
| TW201247179A (en) * | 2011-05-30 | 2012-12-01 | Univ Taipei Medical | Polyelectrolyte complex gels and soft tissue augmentation implants comprising the same |
| CN102516777A (en) * | 2011-11-29 | 2012-06-27 | 苏州大学 | Aqueous solution of silk fibroin and preparation method for aqueous solution |
| CN102560888A (en) * | 2012-01-17 | 2012-07-11 | 东华大学 | Silk fibroin nano-fiber film loaded with water-soluble vitamin E and preparation method for nano-fiber film |
| CN102836465A (en) * | 2012-08-30 | 2012-12-26 | 浙江星月生物科技股份有限公司 | Silk-fibroi and hyaluronic-acid (HA) composite gel for injection and preparation and application thereof |
| WO2014168433A2 (en) * | 2013-04-09 | 2014-10-16 | Kweon Seong Beom | Material composition for promoting hair growth, gray hair melanin regeneration and skin regeneration |
| CN103469351A (en) * | 2013-07-18 | 2013-12-25 | 嘉兴学院 | Preparation method of vitamin C-loaded silk fibroin/hyaluronic acid composite nanofibers |
| CN105688210A (en) * | 2016-03-10 | 2016-06-22 | 陕西瑞凯生物科技有限公司 | Yolk biological protein skin repair dressing and preparation method thereof |
| CN106176281A (en) * | 2016-07-26 | 2016-12-07 | 西安艾尔菲生物科技有限公司 | Carry the fibroin albumen/HA complex microsphere lyophilized powder of active component and preparation and application |
| CN106492279A (en) * | 2016-11-04 | 2017-03-15 | 武汉纺织大学 | A kind of fast preparation method of fibroin albumen hyaluronic acid pluralgel |
| IT201700091328A1 (en) * | 2017-08-07 | 2019-02-07 | Leonardino S R L | Electrospun matrix based on silk proteins, process for its preparation, manufactured articles that include it and their use in therapy and in cosmetics |
| CN108070106A (en) * | 2017-11-22 | 2018-05-25 | 玖久丝绸股份有限公司 | A kind of preparation method of fibroin albumen grafting maltodextrin porous material |
| CN108745216A (en) * | 2018-01-14 | 2018-11-06 | 浙江工商大学 | Preparation method for the silk fibroin powder for making SF-Cd sustained-release micro-spheres |
| CN110237022A (en) * | 2019-07-03 | 2019-09-17 | 斯微(上海) 生物科技有限公司 | A kind of freeze-dried powder, solvent and its application |
| CN111973494A (en) * | 2020-09-22 | 2020-11-24 | 南京飞天一淼科技服务有限公司 | Long-acting moisturizing type moisturizing cream and preparation method thereof |
| CN115463263A (en) * | 2022-08-26 | 2022-12-13 | 上海交通大学医学院附属第九人民医院 | Injectable double-network hydrogel system and preparation method and application thereof |
| CN116966341A (en) * | 2023-08-25 | 2023-10-31 | 杭州雪境医疗器械有限公司 | Preparation method and application of cosmetic filler |
Non-Patent Citations (3)
| Title |
|---|
| Review Research Progress in Enzymatically Cross-Linked Hydrogels as Injectable Systems for Bioprinting and Tissue Engineering;Raquel Naranjo-Alcazar et al;Gels;20230315;1-27 * |
| Stabilization of Natural Antioxidants by Silk Biomaterials;Tingting Luo et al;American Chemical Society;20160503;13573−13582 * |
| 维生素C功能化丝素蛋白纳米纤维的制备和表征;范林鹏;中国优秀硕士学位论文全文数据库工程科技Ⅰ辑;20110815;B016-56 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117599247A (en) | 2024-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111518289B (en) | Injectable self-healing hydrogel with adjustable mechanical properties and preparation method and application thereof | |
| CN110201219A (en) | A kind of composite hydrogel and preparation method thereof of injectable and quick-gelatinizing | |
| CN102936794B (en) | Method for preparing composite nanofiber membrane based on natural material silk fibroin and chitosan | |
| CN111440340B (en) | A kind of silk fibroin-sodium hyaluronate cross-linked double network gel and preparation method thereof | |
| CN107383397B (en) | Hyaluronic acid derivative self-crosslinking hydrogel taking oxidized hydroxyethyl cellulose as crosslinking agent and preparation method thereof | |
| CN105504316B (en) | A kind of active ester cross-linking method of hyaluronic acid methylcellulose plural gel | |
| CN109044963B (en) | A kind of preparation method of pH-sensitive nano hydrogel for injection | |
| CN116747344B (en) | Dialdehyde starch crosslinked amino gelatin hemostatic sponge and preparation method thereof | |
| CN107854729A (en) | A kind of fibroin albumen base self-healing hydrogel and preparation method thereof | |
| CN116870243A (en) | Hydrogel with hemostatic and anti-inflammatory effects and preparation method and application thereof | |
| CN107118361B (en) | A kind of silk fibroin/carboxymethyl chitosan composite gel and preparation method thereof | |
| CN115429935A (en) | A kind of injectable cross-linked chondroitin sulfate hydrogel and preparation method thereof | |
| CN106188609A (en) | A kind of L lysine modified derivatives of hyaluronic acids hydrogel and preparation method thereof | |
| CN111471193A (en) | Dialdehyde polysaccharide nanoparticle crosslinked collagen hydrogel and preparation method thereof | |
| CN114957720A (en) | Self-crosslinking antioxidant PCA-g-CMCS/OSA Schiff base hydrogel and preparation method thereof | |
| CN114470330A (en) | Recombinant collagen gel particles for tissue filling and preparation method thereof | |
| CN117599247B (en) | Silk fibroin microcarrier skin filling preparation, and preparation method and application thereof | |
| CN115845121B (en) | Hemostatic, antibacterial and healing-promoting microgel assembly powder and preparation method thereof | |
| CN108295029A (en) | A kind of injection Multifunctional composite water gel and preparation method thereof | |
| CN115414521A (en) | Bi-component biological glue and application thereof | |
| CN112442200B (en) | Preparation method of bacterial cellulose composite collagen self-assembly material | |
| CN115317661A (en) | Natural polymer composite hydrogel dressing | |
| CN1687498A (en) | Blended fiber of sodium alginate/glutin, preparation method and application thereof | |
| CN111961230A (en) | Arabinoxylan hydrogel with pH responsiveness and preparation method thereof | |
| CN118436071A (en) | A hydrogel for controlling diet and inducing satiety, and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |